
Chinese operating company of SciClone Pharmaceuticals, a specialty pharmaceutical group headquartered in Shanghai and listed on the Hong Kong Stock Exchange under code 6600. In-licenses, markets and sells specialty medicines in China across oncology, infectious disease and critical care, and is best known for the immunomodulator thymalfasin sold as Zadaxin, supported by a large hospital sales force and a portfolio of imported and locally partnered products.
評価を残す